What is the treatment for viral encephalitis, specifically for a patient suspected of having herpes simplex virus (HSV) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Viral Encephalitis

Intravenous aciclovir at a dose of 10 mg/kg every 8 hours should be started immediately in all patients with suspected viral encephalitis, particularly when HSV infection is suspected, without waiting for confirmatory test results. 1, 2

Initial Management

  • Start IV aciclovir within 6 hours of admission if:

    • Initial CSF and/or imaging findings suggest viral encephalitis
    • These results will not be available within 6 hours
    • The patient is very unwell or deteriorating 1
  • Even if initial CSF microscopy or imaging is normal but clinical suspicion of HSV or VZV encephalitis remains, aciclovir should still be started promptly 1

  • Dosing recommendations:

    • Adults and children >12 years: 10 mg/kg IV every 8 hours 2, 3
    • Dose reduction is necessary in patients with pre-existing renal impairment 1, 2

Duration of Treatment

  • Standard treatment duration is 14-21 days for confirmed HSV encephalitis 1, 2
  • Some experts recommend continuing treatment until CSF is negative for virus by PCR 1

Stopping Aciclovir Treatment

Aciclovir can be stopped in immunocompetent patients if:

  1. An alternative diagnosis has been made, OR
  2. HSV PCR in the CSF is negative on two occasions 24-48 hours apart, and MRI is not characteristic for HSV encephalitis, OR
  3. HSV PCR in the CSF is negative once >72 hours after neurological symptom onset, with unaltered consciousness, normal MRI (performed >72 hours after symptom onset), and CSF <5 × 10^6/L white cells 1

Monitoring and Follow-up

  • Regular renal function monitoring is essential during aciclovir treatment 2
  • Consider repeat lumbar puncture at the end of treatment to confirm viral clearance 2
  • Adequate hydration is crucial to prevent aciclovir-induced nephropathy 2

Role of Valaciclovir

  • Oral aciclovir does not achieve adequate CSF levels
  • Valaciclovir (the valine ester of aciclovir) has good oral bioavailability and may have a role in ongoing treatment, particularly in patients with HSV detectable in the CSF after 2-3 weeks of IV therapy 1
  • High-dose valaciclovir (2 g three times daily) is being assessed for extended treatment 1

Role of Corticosteroids

  • Corticosteroids should not be used routinely in patients with HSV encephalitis 1
  • They may have a role under specialist supervision in patients with marked cerebral edema, brain shift, or raised intracranial pressure, but definitive data are lacking 1, 2

Common Pitfalls to Avoid

  1. Delayed treatment initiation: Delays beyond 48 hours significantly worsen outcomes 2, 4
  2. Stopping treatment based on a single negative CSF PCR: Initial CSF PCR can be negative in HSV encephalitis, especially if taken early (<72 hours after symptom onset) 1
  3. Inadequate dosing: Using incorrect aciclovir dosage can lead to treatment failure 2
  4. Failure to consider HSV in differential diagnosis: The most common reason for treatment delay is not considering HSV encephalitis despite suggestive clinical features 4

Special Considerations

  • Brain biopsy has no role in the initial assessment of suspected viral encephalitis but may be considered if no diagnosis is made after the first week, especially with focal abnormalities on imaging 1
  • Poor prognostic factors include advanced age, reduced consciousness, and delays of more than 48 hours between hospital admission and starting treatment 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Viral Encephalitis in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Delays in initiation of acyclovir therapy in herpes simplex encephalitis.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.